ERBB2 and breast cancer: Triple Negative Breast Cancer (TNBC) has a higher engraftment rate as PDXs (~60%) than hormone positive or HER2 + tumors (~10–15%)11, and are therefore the best represented breast cancer subtype in PDX collections.